Stay updated on Jaktinib Hydrochloride Tablets in IPF Clinical Trial
Sign up to get notified when there's something new on the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page.

Latest updates to the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page
- ChecktodayChange DetectedNew links/resources related to **Idiopathic Pulmonary Fibrosis**, including a **Genetic and Rare Diseases Information Center** reference, were added to the study page.SummaryDifference0.2%

- Check7 days agoChange DetectedAdded site revision label v3.5.2 and removed v3.5.0. This update does not modify trial content or user-facing information.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check29 days agoChange DetectedRemoved the 'Interstitial lung disease 2' term and the 'Genetic and Rare Diseases Information Center' entry under Resources.SummaryDifference0.2%

- Check36 days agoChange DetectedThe site revision label was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check43 days agoChange DetectedUpdated the site revision to v3.4.3; the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check72 days agoChange DetectedFooter updated to Revision: v3.4.2. The prior government funding/operating status notice (Revision: v3.4.1) has been removed.SummaryDifference0.5%

Stay in the know with updates to Jaktinib Hydrochloride Tablets in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page.